More than 200000 hospital admissions happen per year for acute pancreatitis and more
than 50000 for chronic pancreatitis in the United States of America. Necrotizing pancreatitis …

Determining the cause of obscure bleeding in the gastrointestinal tract is the key in treating
the disease. Hemosuccus pancreaticus (HP) could be an extremely rare disease. Ordinarily …

Background There is a significant variability in the reported outcomes following
endovascular embolization of arterial pseudoaneurysms in pancreatitis. The objective of this …

Abstract Background and Aim Hemosuccus pancreaticus is considered as one of the rare
cause of upper gastrointestinal bleeding. Intermittent nature of bleeding and lack of …

Hemosuccus pancreaticus is a rare but potentially torrential and life-threatening cause of
acute upper gastrointestinal bleeding. It is described as an intermittent hemorrhage from the …

BACKGROUND Hemosuccus pancreaticus is a very rare but severe form of upper
gastrointestinal hemorrhage. The most common etiology is peripancreatic pseudoaneurysm …

Non-variceal upper gastrointestinal bleeding (NVUGIB) is a common gastroenterological
emergency associated with significant morbidity and mortality. Gastroenterologists and other …

Hemosuccus pancreaticus (bleeding from the pancreatic duct into the gastrointestinal tract
via the ampulla of Vater) is a rare, potentially life-threatening and obscure cause of upper …

CONCLUSIONS An elevated SIRI (≥ 1.9 x 109) is an independent prognostic factor for
patients with metastatic pancreatic cancer treated with mFOLFIRINOX, Gemcitabine plus …

Hemosuccus pancreaticus (HP) defined as bleeding into the pancreatic duct was first
described in 1931 by Lower and Farell. HP also popularly known as wirsungorrhaghia and …